Skip to main content

Table 1 Comparison between the three groups regarding the studied variables using ANOVA test

From: Renal resistive index in non-alcoholic fatty liver disease as an indicator of early renal affection

VariablesGroup 1 (N = 50)Group 2 (N = 50)Group 3 (N = 50)P
BMI (kg/m2)Mean ± SD29.3 ± 2.529.1 ± 1.622.0 ± 1.5< 0.001*
Range24.0–34.325.5–34.518.2–24.5
HGaab
FBG (mg/dL)Mean ± SD88.8 ± 5.684.4 ± 6.777.3 ± 5.9< 0.001*
HGabc
Lipid profileCholesterol (mg/dL)Mean ± SD251.8 ± 38.1224.8 ± 26.2157.1 ± 27.1< 0.001*
HGabc
TG (mg/dL)Mean ± SD225.2 ± 59.2198.8 ± 36.5117.2 ± 17.5< 0.001*
HGabc
LDL (mg/dL)Mean ± SD194.8 ± 22.7182.2 ± 16.3106.2 ± 25.6< 0.001*
HGaab
HDL (mg/dL)Mean ± SD37.4 ± 4.141.1 ± 5.249.8 ± 10.8< 0.001*
 HGabc
 ALT (IU/L)Mean ± SD78.81 ± 17.825.7 ± 7.924.0 ± 7.2< 0.001*
HGabb
AST (IU/L)Mean ± SD69.4 ± 16.723.8 ± 6.923.4 ± 6.9< 0.001*
HGabb
ALP (IU/L)Mean ± SD128.1 ± 31.671.9 ± 23.761.9 ± 14.7< 0.001*
HGabb
GGT (IU/L)Mean ± SD75.1 ± 18.334.1 ± 8.131.8 ± 9.6< 0.001*
HGabb
D. Bil. (mg/dL)Mean ± SD0.60 ± 0.130.60 ± 0.120.62 ± 0.120.559
T. Bil. (mg/dL)Mean ± SD0.16 ± 0.050.15 ± 0.050.15 ± 0.050.730
Albumin (gm/dL)Mean ± SD4.04 ± 0.204.11 ± 0.214.22 ± 0.28< 0.001*
HGaab
Tot. Proteins (gm/dL)Mean ± SD7.29 ± 0.327.32 ± 0.347.36 ± 0.340.630
 Creatinine (mg/dL)Mean ± SD0.87 ± 0.110.73 ± 0.140.66 ± 0.13< 0.001*
 HGabc
 BUN (gm/dL)Mean ± SD14.9 ± 2.313.2 ± 2.911.5 ± 2.8< 0.001*
 HGabc
 eGFR (mL/min)Mean ± SD117.5 ± 5.1118.8 ± 5.0122.0 ± 5.3< 0.001*
 HGaab
 Na (mmol/L)Mean ± SD140.3 ± 2.3140.2 ± 1.9139.7 ± 1.80.294
 K (mmol/L)Mean ± SD4.13 ± 0.284.17 ± 0.314.07 ± 0.200.200
RRIRRIMean ± SD0.66 ± 0.040.63 ± 0.040.61 ± 0.04< 0.001*
Range0.65–0.670.62–0.640.60–0.62
95% CI0.65–0.670.62–0.640.60–0.62
HGabc
  1. CI confidence interval, HG homogenous groups (have the same letter by post hoc test). *Significant